FERITINE LEVELS IN COVID-19 PATIENTS

  • Dewi Astuti Poltekkes Kemenkes Jakarta III
  • Fuas Sitisari
  • Dewi Yunita
  • Eva Ayu Maharani
Keywords: Keyword: COVID-19; Feritin; ICU

Abstract

Bacground: Coronavirus Disease 2019 (COVID-19) is an infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2). COVID-19 causes death both in the world and in Indonesia. Ferritin is an iron storage protein, whose levels can increase during viral infection and can be a marker of viral replication.Methdes: The study design used was a cross-sectional study of 592 secondary data of COVID-19 patients undergoing treatment in the ICU and hospitalizations who carried out ferritin examinations from January to December 2021 at Persahabatan Hospital. Research data were analyzed using the Mann-Whitney Test.Results: The mean value of ferritin levels in ICU patients was 2,406.7 ng/mL and inpatients was 1,249.6 ng/mL. The results of the Mann-Whitney Test obtained a p value of 0.000 <0.05 so that Ho was rejected, which means that there was a significant difference between ferritin levels in patients treated in the ICU and hospitalized at Persahabatan Hospital.Conclusion: There is a significant difference between ferritin levels in COVID-19 patients treated in the ICU and hospitalized in Persahabatan Hospital. Examination of ferritin levels can indicate severe inflammation in COVID-19 patients.

 

 

References

[1] Baraboutis IG, Gargalianos P, Aggelonidou E, Adraktas A. Pengalaman kehidupan nyata awal dari Pusat COVID-19 yang ditunjuk di Athena. Yunani: algoritme terapi yang diusulkan. SN Compr Clin Med. 2020;1-5.
[2] Dimopoulos, G., de Mast, Q., Markou, N., Theodorakopoulou, M., Komnos, A., Mouktaroudi, M., Netea, M. G., Spyridopoulos, T., Verheggen, R. J., Hoogerwerf, J., Lachana, A., van de Veerdonk, F. L., & Giamarellos- Bourboulis, E. J. (2020). Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis. Cell Host and Microbe, 28(1), 117-123.e1. https://doi.org/10.1016/j.chom.2020.05.007
[3] Hikmawati, I., & Setiyabudi, R. (2020). Hipertensi Dan Diabetes Militus Sebagai Penyakit Penyerta Utama Covid-19 Di Indonesia Hypertension and Diabetes Mellitus As Covid-19 Comorbidities in Indonesia. Prosiding Seminar Nasional Lppm Ump, 0(0), 95–100.
[4] Keputusan Menteri Kesehatan Republik Indonesia. (2020). Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MenKes/413/2020 Tentang Pedoman Pencegahan dan Pengendalian Corona Virus Disease 2019 (Covid- 19). MenKes/413/2020, 2019, 207.
[5] Linlin Cheng et all. Ferritin in the coronavirus disease 2019 (COVID-19): A systemic review and meta-analysis. J. Clin Lab Anal. 2020 Okt 34(10), 1-18.
[6] Sun, P., Lu, X., Xu, C., Sun, W., & Pan, B. (2020). Understanding of COVID-19 based on current evidence. Journal of Medical Virology, 92(6), 548–551. https://doi.org/10.1002/jmv.25722
[7] Susilo, A., Rumende, C. M., Pitoyo, C. W., Santoso, W. D., Yulianti, M., Sinto, R., Singh, G., Nainggolan, L., Nelwan, E. J., Khie, L., Widhani, A., Wijaya, E., Wicaksana, B., Maksum, M., Annisa, F., Jasirwan, O. M., Yunihastuti, E., Penanganan, T., New, I., … Cipto, R. (2020). Coronavirus Disease 2019 : Tinjauan Literatur Terkini Coronavirus Disease 2019 : Review of Current Literatures. Jurnal Penyakit Dalam Indonesia, 7(1), 45–67.
Published
2023-05-23
How to Cite
Astuti, D., Sitisari, F., Yunita, D., & Maharani, E. (2023). FERITINE LEVELS IN COVID-19 PATIENTS. Jurnal Fisioterapi Dan Kesehatan Indonesia, 3(1), 136-140. https://doi.org/10.59946/jfki.2023.169